bluebird bio Inc. (NASDAQ: BLUE) Stock Information | RedChip

bluebird bio Inc. (NASDAQ: BLUE)


$8.4050
-0.8250 ( -8.64% ) 512.5K

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Market Data


Open


$8.4050

Previous close


$9.2300

Volume


512.5K

Market cap


$89.74M

Day range


$8.2010 - $9.7630

52 week range


$5.8000 - $38.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Dec 13, 2024
4 Insider transactions 2 Dec 12, 2024
4 Insider transactions 2 Dec 12, 2024
8-k 8K-related 13 Dec 04, 2024
10-q Quarterly Reports 89 Nov 14, 2024
8-k 8K-related 14 Nov 14, 2024
4 Insider transactions 2 Nov 08, 2024
4 Insider transactions 2 Nov 08, 2024
4 Insider transactions 2 Nov 08, 2024
4 Insider transactions 2 Nov 08, 2024

Latest News